Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen (Q80222693)
Jump to navigation
Jump to search
scientific article published on 06 September 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen |
scientific article published on 06 September 2006 |
Statements
Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen (English)
Rosa Ruiz-Valderas
Josefa Ruiz-Morales
Eva Leon
Antonio Vergara de Campos
Fernando Lozano
Rebeca Valiente
6 September 2006